Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 May;10(5):645-58.
doi: 10.1586/erv.11.28.

Tuberculosis vaccines in clinical trials

Rosalind Rowland  1 , Helen McShane
Affiliations
Review

Tuberculosis vaccines in clinical trials

Rosalind Rowland et al. Expert Rev Vaccines. 2011 May.

Abstract

Effective prophylactic and/or therapeutic vaccination is a key strategy for controlling the global TB epidemic. The partial effectiveness of the existing TB vaccine, bacille Calmette-Guérin (BCG), suggests effective vaccination is possible and highlights the need for an improved vaccination strategy. Clinical trials are evaluating both modifications to the existing BCG immunization methods and also novel TB vaccines, designed to replace or boost BCG. Candidate vaccines in clinical development include live mycobacterial vaccines designed to replace BCG, subunit vaccines designed to boost BCG and therapeutic vaccines designed as an adjunct to chemotherapy. There is a great need for validated animal models, identification of immunological biomarkers of protection and field sites with the capacity for large-scale efficacy testing in order to develop and license a novel TB vaccine or regimen.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Daniel TM. The history of tuberculosis. Respir. Med. 2006;100(11):1862–1870. - PubMed
    1. WHO BCG vaccine. WHO position paper. Wkly Epidemiol. Rec. 2004;79(4):27–38. - PubMed
    1. Onozaki I, Raviglione M. Stopping tuberculosis in the 21st Century: goals and strategies. Respirology. 2010;15(1):32–43. - PubMed
    1. Saltini C. Chemotherapy and diagnosis of tuberculosis. Respir. Med. 2006;100(12):2085–2097. - PubMed
    1. Dye C, Williams BG. The population dynamics and control of tuberculosis. Science. 2010;328(5980):856–861. - PubMed

Websites

    1. The Effect of Bacille Calmette–Guérin (BCG) Vaccination on Immune Responses in HIV-Exposed and Unexposed Infants. http://clinicaltrials.gov/ct2/show/NCT00331474.
    1. Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination. http://clinicaltrials.gov/ct2/show/NCT01119521.
    1. BCG Vaccination Delivered Intradermally, Orally and by Combined Routes. http://clinicaltrials.gov/ct2/show/NCT00396370.
    1. Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries? http://clinicaltrials.gov/ct2/show/NCT00146302.
    1. Sex-Differential Health Interventions In Low-Birth-Weight Infants. http://clinicaltrials.gov/ct2/show/NCT00625482.